HARBOR BIOSCIENCES INC COM STK (DE)
HRBR
HRBR was delisted on the 22nd of September, 2010.
2 hedge funds and large institutions have $50K invested in HARBOR BIOSCIENCES INC COM STK (DE) in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
33% less funds holding
Funds holding: 3 → 2 (-1)
93% less capital invested
Capital invested by funds: $719K → $50K (-$669K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DC
Diametric Capital
Boston,
Massachusetts
|
-$677K |
HRBR Hedge Fund Activity: Q1 2022 in Review
2 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in HARBOR BIOSCIENCES INC COM STK (DE) (HRBR) for Q1 2022, worth a combined $50K — down 93% from $719K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of HRBR and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Diametric Capital, exiting entirely with an estimated $677K sold.
- 2 institutional investors held HARBOR BIOSCIENCES INC COM STK (DE) (HRBR) as of Q1 2022, down from 3 in Q4 2021.
- Funds reported $50K of HARBOR BIOSCIENCES INC COM STK (DE) stock for Q1 2022, down 93% quarter-over-quarter.
- 0 funds opened new HARBOR BIOSCIENCES INC COM STK (DE) positions in Q1 2022 and 1 closed out, a net change of -1 holder.
- The largest HARBOR BIOSCIENCES INC COM STK (DE) seller in Q1 2022 was Diametric Capital, an estimated $677K sold.
Based on aggregated 13F filings for Q1 2022.